Benjamin Tomlinson
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant (NCT06129734) | Benjamin Tomlinson | 2025-07-28 |
| Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies (NCT04732845) | Benjamin Tomlinson | 2021-04-26 |
| 5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies (NCT04187703) | Benjamin Tomlinson | 2020-11-16 |
| AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma (NCT03434769) | Benjamin Tomlinson | 2018-07-09 |
Track Benjamin Tomlinson automatically
Every clearance here is in the API, with alerts when new ones post.